Accelerated Approval Procedure: How to Demonstrate the High Therapeutic Benefits?

What requirements are to be met for recognition of an accelerated approval procedure, in order to be able to demonstrate fulfilment of criterion c – “high therapeutic benefit”?

A summary of 15 to max. 30 pages is expected for the application for an accelerated approval procedure. criterion c, supported by a description of the studies performed is often responsible for the rejection of an application.. Information on the design of the clinical trials, primary outcomes, and a summary of the results on efficacy and safety should be provided. Complete clinical reports are not to be submitted. The applicant should also evaluate the data on efficacy and safety (as in a Clinical Overview) and, based on this data, give reasons why a high therapeutic benefit can be expected.

Your contact

Any questions?
I would be delighted to answer them.

Dr. Katharina Oehler
Scientific and Managing Director
T +41 44 787 70 20
Send email


You might also find this interesting

We also pass on our knowledge at events:
Decades of experience and knowledge – these are our employees:
We have been committed to serving our clients enthusiastically and cooperatively since 1997: